Search research articles
Contact Us
Filters
Showing results (121-130 of 150) with videos related to
Page
of 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII
A Wallgren, M Bonetti, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
M M Regan, O Pagani, B Walley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
E Munzone, A Giobbie-Hurder, B A Gusterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
A Keshaviah, S Dellapasqua, N Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
M Colleoni, S Gelber, A S Coates, et al.
British Journal of Cancer
|
November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
J Bernhard, D Zahrieh, J J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX
S Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer
P Karlsson, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2009
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
M Rabaglio, Z Sun, K N Price, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 150) with videos related to
Sort By:
Page
of 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2003
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII
A Wallgren, M Bonetti, R D Gelber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
M M Regan, O Pagani, B Walley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
E Munzone, A Giobbie-Hurder, B A Gusterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
A Keshaviah, S Dellapasqua, N Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
M Colleoni, S Gelber, A S Coates, et al.
British Journal of Cancer
|
November 29, 2007
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
J Bernhard, D Zahrieh, J J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX
S Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer
P Karlsson, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2009
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
M Rabaglio, Z Sun, K N Price, et al.
Page
of 15